Abstract
Naked DNA vaccines represent an attractive approach for generating antigen-specific immunity because of their stability and simplicity of delivery. There are particular concerns with DNA vaccines however, such as potential integration into the host genome, cell transformation, and limited potency. The usage of DNA-based alphaviral RNA replicons (suicidal DNA vectors) may alleviate the concerns of integration or transformation since suicidal DNA vectors eventually cause lysis of transfected cells. To improve further the potency of suicidal DNA vaccines, we evaluated the effect of linking Mycobacterium tuberculosis heat shock protein 70 (Hsp70) to human papillomavirus type 16 (HPV-16) E7 as a model antigen on antigen-specific immunity generated by a DNA-based Semliki Forest virus (SFV) RNA vector, pSCA1. Our results indicated that this suicidal DNA vaccine containing E7/Hsp70 fusion genes generated significantly higher E7-specific T cell-mediated immune responses than vaccines containing the wild-type E7 gene in vaccinated mice. More importantly, this fusion converted a less effective vaccine into one with significant potency against established E7-expressing metastatic tumors. The antitumor effect was predominantly CD8-dependent. These results indicate that linkage of Hsp70 to the antigen may greatly enhance the potency of suicidal DNA vaccines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Robinson HL . Nucleic acid vaccines: an overview Vaccine 1997 15: 785–787
Donnelly JJ, Ulmer JB, Shiver JW, Liu MA . DNA vaccines Annu Rev Immunol 1997 15: 617–648
Ying H et al. Cancer therapy using a self-replicating RNA vaccine Nature Med 1999 5: 823–827
Berglund P et al. Enhancing immune responses using suicidal DNA vaccines Nat Biotechnol 1998 16: 562–565
Leitner WW et al. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors Cancer Res 2000 60: 51–55
DiCiommo DP, Bremner R . Rapid, high level protein production using DNA-based Semliki Forest virus vectors J Biol Chem 1998 273: 18060–18066
Wu TC . Immunology of the human papilloma virus in relation to cancer Curr Opin Immunol 1994 6: 746–754
Chen C-H et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene Cancer Res 2000 60: 1035–1042
Janetzki S, Blachere NE, Srivastava PK . Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96 J Immunother 1998 21: 269–276
Heikema A, Agsteribbe E, Wilschut J, Huckriede A . Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides Immunol Lett 1997 57: 69–74
Ciupitu AM et al. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes J Exp Med 1998 187: 685–691
Suzue K, Young RA . Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24 J Immunol 1996 156: 873–879
Chen CH, Wu TC . Experimental vaccine strategies for cancer immunotherapy J Biomed Sci 1998 5: 231–252
Pardoll DM . Cancer vaccines Nature Med 1998 4: 525–531
Wang RF, Rosenberg SA . Human tumor antigens for cancer vaccine development Immunol Rev 1999 170: 85–100
Huang AY et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens Science 1994 264: 961–965
Frolov I, Schlesinger S . Translantion of Sindbis virus mRNA: analysis of sequences downstream of the initiating AUG condon that enhance translation J Virol 1996 70: 1182–1190
Barrios C, Georgopoulos C, Lambert PH, Del Giudice G . Heat shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen Clin Exp Immunol 1994 98: 229–233
Suzue K, Zhou X, Eisen HN, Young RA . Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway Proc Natl Acad Sci USA 1997 94: 13146–13151
Anthony LS et al. Priming of CD8+ CTL effector cells in mice by immunization with a stress protein-influenza virus nucleoprotein fusion molecule Vaccine 1999 17: 373–383
Mitchell DA, Nair SK, Gilboa E . Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells Eur J Immunol 1998 28: 1923–1933
Suto R, Srivastava PK . A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides Science 1995 269: 1585–1588
Arnold-Schild D et al. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells J Immunol 1999 162: 3757–3760
Cho BK et al. A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins Immunity 2000 12: 263–272
Lukas J et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 J Cell Biol 1994 125: 625–638
Heck DV, Yee CL, Howley PM, Munger K . Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses Proc Natl Acad Sci USA 1992 89: 4442–4446
Lin K-Y et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen Cancer Res 1996 56: 21–26
Feltkamp MC et al. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells Eur J Immunol 1993 23: 2242–2249
Tindle RW, Fernando GJ, Sterling JC, Frazer IH . A ‘public’ T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes Proc Natl Acad Sci USA 1991 88: 5887–5891
Wu T-C et al. Engineering an intracellular pathway for MHC class II presentation of HPV-16 E7 Proc Natl Acad Sci USA 1995 92: 11671–11675
Dialynas DP et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule J Immunol 1983 131: 2445–2451
Sarmiento M, Glasebrook AL, Fitch FW . IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement J Immunol 1980 125: 2665–2672
Koo GC et al. The NK-1.1(−) mouse: a model to study differentiation of murine NK cells J Immunol 1986 137: 3742–3747
Acknowledgements
We would like to thank Dr Rod Bremner for providing the pSCA1 vector. We also appreciate helpful discussions with Drs Drew M Pardoll and Robert J Kurman. We would also like to thank Dr Richard Roden for critical review of the manuscript. This project was supported by the National Cancer Institute and the American Cancer Society. Dr Hsu was supported by the National Science Council of Taiwan (NSC89-2314-B006-104).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hsu, KF., Hung, CF., Cheng, WF. et al. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther 8, 376–383 (2001). https://doi.org/10.1038/sj.gt.3301408
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301408
Keywords
This article is cited by
-
Immunization with a suicidal DNA vaccine expressing the E glycoprotein protects ducklings against duck Tembusu virus
Virology Journal (2018)
-
Perspectives for therapeutic HPV vaccine development
Journal of Biomedical Science (2016)
-
Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice
Archives of Virology (2015)
-
Immunologic treatments for precancerous lesions and uterine cervical cancer
Journal of Experimental & Clinical Cancer Research (2014)
-
Tumormarker und Prognosefaktoren bei Plattenepithelkarzinomen der Kopf-Hals-Region
HNO (2010)